Publications by authors named "Brendan Koop"

Claim this Profile
P
Pulsed Field Ablation in Patients With Cardiac Implantable Electric Devices: Vigilance Is Warranted.
Brendan E Koop, Elizabeth M Albrecht, Emily Lecy, James Kippola

Pacing Clin Electrophysiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent ventricular lesion formation using a novel large-area pulsed field ablation catheter: A preclinical feasibility study.
Thomas Kueffer, Daniela Casoni, Christine Goepfert, Olgica Beslac, Chiara Parodi, Brendan Koop

Heart Rhythm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fundamentals of System Design for Cardiac Pulsed Field Ablation: Optimization of Safety, Efficacy, and Usability.
Brendan Koop

Pacing Clin Electrophysiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lesion Formation in Cardiac Pulsed-Field Ablation: Acute to Chronic Cellular Level Changes.
Kara Garrott, Savannah Bifulco, David Ramirez, Brendan Koop

Pacing Clin Electrophysiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Spasm Due to Pulsed Field Ablation: A State-of-the-Art Review.
David A Ramirez, Kara Garrott, Ann Garlitski, Brendan Koop

Pacing Clin Electrophysiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study.
Karel T N Breeman, Bryan Swackhamer, Amy J Brisben, Anne-Floor B E Quast, Nathan Carter, Brendan E Koop

Heart Rhythm· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on intrabody communication.
Anne-Floor B E Quast, Fleur V Y Tjong, Brendan E Koop, Arthur A M Wilde, Reinoud E Knops

Europace· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
Fleur V Y Tjong, Tom F Brouwer, Brendan Koop, Brian Soltis, Allan Shuros

JACC Clin Electrophysiol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator.
Fleur V Y Tjong, Tom F Brouwer, Kirsten M Kooiman, Lonneke Smeding, Brendan Koop

J Am Coll Cardiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model of fracture testing of soft viscoelastic tissues.
Brendan E Koop, Jack L Lewis

J Biomech· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of displacement rate and proteoglycan digestion on the fracture resistance of tissue grown from chondrocyte culture.
Brendan E Koop, Jack L Lewis, Michelle M Fedewa, Theodore R Oegema

J Mater Sci Mater Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis